NuCana's (NCNA) Buy Rating Reaffirmed at Truist Financial

Truist Financial reiterated their buy rating on shares of NuCana (NASDAQ:NCNA – Free Report) in a report published on Wednesday morning, Benzinga reports. Truist Financial currently has a $6.00 price target on the stock. Separately, Oppenheimer reiterated an outperform rating and issued a $4.00 price objective on shares of NuCana in a research report on […]

Related Keywords

,Acadian Asset Management ,Citadel Advisors ,Virtu Financial ,Renaissance Technologies ,Carlyle Group Inc ,Truist Financial ,Free Report ,Cana Stock Down ,Get Free Report ,Asset Management ,Nucana Daily ,Nucana ,Nasdaq Ncna ,Ncna ,Medical ,Reiterated Rating ,Truist Financial Co ,